Modeling somatic evolution in tumorigenesis. PLoS Comput Biol 2(8):e108

Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
PLoS Computational Biology (Impact Factor: 4.62). 09/2006; 2(8):e108. DOI: 10.1371/journal.pcbi.0020108
Source: PubMed


Tumorigenesis in humans is thought to be a multistep process where certain mutations confer a selective advantage, allowing lineages derived from the mutated cell to outcompete other cells. Although molecular cell biology has substantially advanced cancer research, our understanding of the evolutionary dynamics that govern tumorigenesis is limited. This paper analyzes the computational implications of cancer progression presented by Hanahan and Weinberg in The Hallmarks of Cancer. We model the complexities of tumor progression as a small set of underlying rules that govern the transformation of normal cells to tumor cells. The rules are implemented in a stochastic multistep model. The model predicts that (i) early-onset cancers proceed through a different sequence of mutation acquisition than late-onset cancers; (ii) tumor heterogeneity varies with acquisition of genetic instability, mutation pathway, and selective pressures during tumorigenesis; (iii) there exists an optimal initial telomere length which lowers cancer incidence and raises time of cancer onset; and (iv) the ability to initiate angiogenesis is an important stage-setting mutation, which is often exploited by other cells. The model offers insight into how the sequence of acquired mutations affects the timing and cellular makeup of the resulting tumor and how the cellular-level population dynamics drive neoplastic evolution.

Download full-text


Available from: Sabrina L Spencer, Aug 03, 2014
  • Source
    • "Although, all of these pathways have been extensively studied and associated with OC, progress has been limited, since first-line therapy and 5-year survival rates have largely remained unchanged. Over the years, researchers have centered their explanation of the acquisition of a single malignant trait by a neoplastic cell, such as its invasive capacity or autonomy of proliferation, on a mutation (Spencer et al., 2006; Vogelstein and Kinzler, 1993). Nevertheless, in addition to genomic traits and the epigenetic landscape, which includes regulatory networking genes in the genome, signaling proteins and miRNAs play an important role in cancer development and treatment design that has been partially dismissed (see (Huang, 2013) for a review). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ovarian Cancer (OC) is the most lethal gynecological malignancy among women. Over 70% of women with OC are diagnosed in advanced stages and most of these cases are incurable. Although most patients respond well to primary chemotherapy, tumors become resistant to treatment. Mechanisms of chemoresistance in cancer cells may be associated with mutational events and/or alterations of gene expression through epigenetic events. Although focusing on known genes has already yielded new information, previously unknown non-coding RNAs, such as microRNAs (miRNAs), also lead insight into the biology of chemoresistance. In this review we summarize the current evidence examining the role of miRNAs as biomarkers of response and survival to therapy in OC. Beside their clinical implications, we also discuss important differences between studies that may have limited their use as clinical biomarkers and suggest new approaches.
    Molecular and Cellular Endocrinology 04/2014; 390(1). DOI:10.1016/j.mce.2014.03.006 · 4.41 Impact Factor
  • Source
    • "Extracellular regulation by growth factors is partially due to continuous models (PDEs). Such discrete-continuous models are usually called hybrid models [12] [31] [43] [45] [46] [51] [55]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The production and regulation of red blood cells, erythropoiesis, occurs in the bone marrow where erythroid cells proliferate and differentiate within particular structures, called erythroblastic islands. A typical structure of these islands consists of a macrophage (white cell) surrounded by immature erythroid cells (progenitors), with more mature cells on the periphery of the island, ready to leave the bone marrow and enter the bloodstream. A hybrid model, coupling a continuous model (ordinary differential equations) describing intracellular regulation through competition of two key proteins, to a discrete spatial model describing cell-cell interactions, with growth factor diffusion in the medium described by a continuous model (partial differential equations), is proposed to investigate the role of the central macrophage in normal erythropoiesis. Intracellular competition of the two proteins leads the erythroid cell to either proliferation, differentiation, or death by apoptosis. This approach allows considering spatial aspects of erythropoiesis, involved for instance in the occurrence of cellular interactions or the access to external factors, as well as dynamics of intracellular and extracellular scales of this complex cellular process, accounting for stochasticity in cell cycle durations and orientation of the mitotic spindle. The analysis of the model shows a strong effect of the central macrophage on the stability of an erythroblastic island, when assuming the macrophage releases pro-survival cytokines. Even though it is not clear whether or not erythroblastic island stability must be required, investigation of the model concludes that stability improves responsiveness of the model, hence stressing out the potential relevance of the central macrophage in normal erythropoiesis.
    Journal of Theoretical Biology 04/2012; 298:92-106. DOI:10.1016/j.jtbi.2012.01.002 · 2.12 Impact Factor
  • Source
    • "Niche boundaries initially constrain further growth of the clone, so once the initial niche is filled, clonal expansion proceeds by a much slower process of pre-malignant niche replication or invasion and takeover of adjacent normal niches by pre-malignant cells [57], [58], [59], [60], [61]. This slow process occurs on the scale of multiple years and decades in humans (and months in mice), and may involve acquisition of new mutations [62]. Each pre-malignant cell in any niche has some probability of transforming into a fully malignant cell and, after some lag time (L), into a tumor [8], [48], [49]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Different types of ionizing radiation produce different dependences of cancer risk on radiation dose/dose rate. Sparsely ionizing radiation (e.g. γ-rays) generally produces linear or upwardly curving dose responses at low doses, and the risk decreases when the dose rate is reduced (direct dose rate effect). Densely ionizing radiation (e.g. neutrons) often produces downwardly curving dose responses, where the risk initially grows with dose, but eventually stabilizes or decreases. When the dose rate is reduced, the risk increases (inverse dose rate effect). These qualitative differences suggest qualitative differences in carcinogenesis mechanisms. We hypothesize that the dominant mechanism for induction of many solid cancers by sparsely ionizing radiation is initiation of stem cells to a pre-malignant state, but for densely ionizing radiation the dominant mechanism is radiation-bystander-effect mediated promotion of already pre-malignant cell clone growth. Here we present a mathematical model based on these assumptions and test it using data on the incidence of dysplastic growths and tumors in the mammary glands of mice exposed to high or low dose rates of γ-rays and neutrons, either with or without pre-treatment with the chemical carcinogen 7,12-dimethylbenz-alpha-anthracene (DMBA). The model provides a mechanistic and quantitative explanation which is consistent with the data and may provide useful insight into human carcinogenesis.
    PLoS ONE 12/2011; 6(12):e28559. DOI:10.1371/journal.pone.0028559 · 3.23 Impact Factor
Show more